EnBio Co. Ltd.
Enbio Co., Ltd. produces and sells pesticides in South Korea. It offers fungi-insecticides, fungicides, insecticides, herbicides, plant growth regulars, and fertilizers. The company was founded in 1997 and is headquartered in Gunpo-si, South Korea.
EnBio Co. Ltd. (352940) - Total Assets
Latest total assets as of June 2025: ₩69.90 Billion KRW
Based on the latest financial reports, EnBio Co. Ltd. (352940) holds total assets worth ₩69.90 Billion KRW as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
EnBio Co. Ltd. - Total Assets Trend (2017–2024)
This chart illustrates how EnBio Co. Ltd.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
EnBio Co. Ltd. - Asset Composition Analysis
Current Asset Composition (December 2024)
EnBio Co. Ltd.'s total assets of ₩69.90 Billion consist of 59.7% current assets and 40.3% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩933.93 Million | 0.0% |
| Accounts Receivable | ₩13.38 Billion | 19.7% |
| Inventory | ₩19.37 Billion | 28.6% |
| Property, Plant & Equipment | ₩19.69 Billion | 29.1% |
| Intangible Assets | ₩1.30 Billion | 1.9% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how EnBio Co. Ltd.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: EnBio Co. Ltd.'s current assets represent 59.7% of total assets in 2024, a decrease from 66.7% in 2017.
- Cash Position: Cash and equivalents constituted 0.0% of total assets in 2024, the same as 0.0% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, a decrease from 6.0% in 2017.
- Asset Diversification: The largest asset category is property, plant & equipment at 29.1% of total assets.
EnBio Co. Ltd. Competitors by Total Assets
Key competitors of EnBio Co. Ltd. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
China Tianying Inc
SHE:000035
|
China | CN¥32.41 Billion |
|
HeiLongJiang Kingland Technology Co Ltd
SHE:000711
|
China | CN¥1.22 Billion |
|
BECE Legend Group Co Ltd
SHE:000803
|
China | CN¥5.22 Billion |
|
Tus-Sound Environmental Resources Co Ltd
SHE:000826
|
China | CN¥18.67 Billion |
|
Wangneng Environment Co Ltd
SHE:002034
|
China | CN¥14.26 Billion |
|
Beijing Orient Landscape Co Ltd
SHE:002310
|
China | CN¥3.37 Billion |
|
JAG Bhd
KLSE:0024
|
Malaysia | RM314.48 Million |
|
Qiaoyin Environmental Tech Co Ltd
SHE:002973
|
China | CN¥8.47 Billion |
EnBio Co. Ltd. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - EnBio Co. Ltd. generates 0.53x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, EnBio Co. Ltd. generates $ 0.95 in net profit.
EnBio Co. Ltd. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.06 | 1.94 | 1.65 |
| Quick Ratio | 1.31 | 1.24 | 1.29 |
| Cash Ratio | 0.00 | 0.04 | 0.00 |
| Working Capital | ₩21.91 Billion | ₩ 23.42 Billion | ₩ 18.00 Billion |
EnBio Co. Ltd. - Advanced Valuation Insights
This section examines the relationship between EnBio Co. Ltd.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.55 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 2.2% |
| Total Assets | ₩67.77 Billion |
| Market Capitalization | $10.20 Million USD |
Valuation Analysis
Below Book Valuation: The market values EnBio Co. Ltd.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: EnBio Co. Ltd.'s assets grew by 2.2% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for EnBio Co. Ltd. (2017–2024)
The table below shows the annual total assets of EnBio Co. Ltd. from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩67.77 Billion | +2.19% |
| 2023-12-31 | ₩66.32 Billion | -24.09% |
| 2022-12-31 | ₩87.36 Billion | -3.58% |
| 2021-12-31 | ₩90.60 Billion | +26.76% |
| 2020-12-31 | ₩71.48 Billion | +15.04% |
| 2019-12-31 | ₩62.13 Billion | +9.87% |
| 2018-12-31 | ₩56.55 Billion | +12.65% |
| 2017-12-31 | ₩50.20 Billion | -- |